knowledge -WSS

knowledge

author：hotspot 2025-09-27 07:44:07 - browse：7

Illustration of a crowd of people looking toward a cityscape. — Adobe

Few public health challenges have been more daunting and persistent than the opioid crisis, which started because of egregious conduct by opioid manufacturers and now is driven by an influx of fentanyl. In my home state of New Hampshire — which has been at the forefront of this heartbreaking epidemic for more than a decade — too many promising futures have been snatched away. As we look to the next stage of bipartisan efforts to take on this challenge, we must quickly reauthorize and expand the SUPPORT Act, which expired Sept. 30. It laid a new foundation for our response to this epidemic — and now it can be used to increase access to the gold standard of treatment for addiction.

In 2018, we came together across party lines to pass the SUPPORT Act, which established vital infrastructure for communities in New Hampshire and across the country to treat addiction, help people recover, and prevent substance misuse in the first place.

While there are dozens of vital measures in this legislation, one of the most critical provisions helped expand access to medication-assisted treatment, the gold standard of addiction care. Access to this lifesaving medication, buprenorphine, has historically been limited by law and clinician reluctance, fueled by harmful stigmas surrounding addiction treatment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Wikipedia

WSS

Trans patients at the end of life deserve respect and dignity

'Patient friction coefficient' can gauge a clinical trial's patient burden

Health officials lay out plans to cope with respiratory virus season

Abortion policy in the spotlight at Republican debate

Diabetes management: Digital health tools fall short, study says

Study: Spinal cord stimulation helps patients with paralysis walk again

focus

knowledge

hotspot

Walensky prepares to leave CDC — and Congress — behind

Medicare Advantage insurers pressure Biden for bigger payments

The cancer drug shortage isn’t new — and neither are the solutions

With Wegovy coverage, Medicare patients may face high costs

DIEP, the 'gold standard' of breast reconstruction, is under threat

Republicans love RFK Jr. What's that tell us about health in 2024?

Affirmative action in medical school literally saved lives

Yancopoulos of Regeneron works to expand Dupixent success

In Memoriam: Notable people who died in 2023

With Wegovy coverage, Medicare patients may face high costs

explore

Trans patients at the end of life deserve respect and dignity

Listen: Vivek Ramaswamy's star turn & leaky drug data

Listen: Vivek Ramaswamy's star turn & leaky drug data

As obesity drug market grows, telehealth companies court payers

Texas board proposes rules on abortion law emergency exemption

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Wikipedia

hotspot

hotspot

focus